Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if treatment with Mucinex D lowers the use of
antibiotics in the treatment of upper respiratory infection when compared to placebo
Phase:
Phase 4
Details
Lead Sponsor:
Reckitt Benckiser Inc. Reckitt Benckiser LLC
Treatments:
Chlorpheniramine, phenylpropanolamine drug combination Ephedrine Guaifenesin Phenylpropanolamine Pseudoephedrine